Background: Hepatitis C virus has global burden, but it is a potentially curable disease, with sustained virologic response among the majority of treated patients. In recent years, new treatments for hepatitis C have been approved and represent a major advancement in treatment. Objectives: This study was conducted to assess knowledge, opinions and perceived barriers to hepatitis c direct-Acting Antivirals (DAAs) based regimen among a sample of hepatitis C virus (HCV) treatment providers. Methods: A Cross-sectional study on HCV treatment providers at El-Demerdash, Ain Shams University Hospital was conducted. A total of 69 physicians responded to self-administered questionnaire about their knowledge, opinions on the services provided and perception towards treatment barriers. Results: Most of physicians' opinions agreed with the current state of HCV care as exist of guidelines, patients have adequate access to HCV treatment providers; but they disagreed about that the general public is aware of HCV and know that it is a curable disease. Most of physicians (81%) had high Knowledge level of HCV treatment principles. The most perceived barriers to care were Payer-related barriers followed by government-related barriers and patient-related barriers.
Introduction:
Hepatitis C virus (HCV) infection is an important global health issue. It is estimated that a significant part of the world population is chronically infected with the virus where 130-150 million people live with chronic HCV infection, and about 350,000-500,000 HCV-related deaths occur each year. Acute HCV progresses to chronic infection in 55-85% of cases; 15-30% of these will develop complications of chronic liver disease, such as liver cirrhosis, and 1-5% will develop liver cancer. 2, 3, 4 Hepatitis C virus (HCV) has high genetic diversity with regional variations in genotype prevalence which gives challenge in development of vaccines and pan-genotypic treatments. 5 The HCV is a potentially curable disease, developments in hepatitis C treatment gained speed in the last decade. Several new treatment options are emerging and are available to a large part of the affected population with promise of a sustained Egyptian Family Medicine Journal (EFMJ) Vol . 3 (2), Nov. 2019 http://efmj.journals.ekb.eg/ virologic response (SVR) among the majority of treated patients. 6 However, in developing countries, there is limited access to hepatitis treatment due to defects in their health systems and insurance coverage, absence of local and national political support in fighting the infection, lack of trained personnel, and lack of diagnostics. 7 In Egypt, HCV is a major public health problem and according to Egypt Health Issues Survey (EHIS) (2015) results, the prevalence of HCV antibody in the 15-59 year age groups was found to be 10.0% while HCV RNA was 7.0% and approximately, 3.7 million persons have chronic HCV infection. 2 Therefore, an estimated 29% reduction in HCV RNA prevalence has been seen since 2008, which attributed to prevention efforts and the ageing of the group infected 40-50 years ago during the mass schistosomiasis treatment campaigns. 17 Sampling method: Systematic random sampling involved randomly selecting two days per week, and this random selection repeated every week for two months period with exclusion of weekends then took available physicians working at HCV treatment clinic at selected days.
Sample size:
A sample size of 65 produces a two-sided 95% confidence interval with a distance from the mean to the limits that is equal to 1 when the estimated standard deviation is 4.0 according to McGowan et.al, 2013. 7 Each response for knowledge was rated with 0 representing "wrong answer" 5, representing "don't know" and 10
Data collection tool:
representing "right answer". Then composite score was calculated for each physician with maximum total score of 260. representing "not a barrier to treatment," 5
representing "somewhat of a barrier to treatment," and 10 representing "large barrier to treatment."
A composite score for each dimension of barriers was calculated for each physician.
Therefore, Total score of patient related barriers was 120, Total score of government related barriers was 30, Total score of provider related barriers was 70 and Total score of payer related barriers was 90.
Data management and analysis:
Data were managed with Statistical Package 
Ethical consideration:
Administrative approval from Ain Shams University hospitals was obtained.
Researchers explained the purpose of the study and informed the participants about their rights, assuring them that the collected data will not be used for any purpose other than for the present study and that the data will be handled anonymously and Informed Egyptian Family Medicine Journal (EFMJ) Vol .3(2), Nov. 2019 http://efmj.journals.ekb.eg/ consents were taken from physicians before their participation in the study. Table-4 and Table-5 .
Results

Correlation between knowledge score and scores of different dimensions of barriers:
It is evident there is a statistically significant correlation between knowledge score and scores of perceived patients' and providers' related barriers (r= -0.396 &.338 respectively) as found in Table-6 .
Discussion:
The current study gave an a clear view as it was similar to that found in study conducted on primary healthcare physicians in Baltimore. 6, 15 On other hand, minority of physicians in current study agreed about "the general public is aware of HCV" (45.6%), "most patients are aware that HCV is curable" (30.4%), and Kingdom addressed that those patient level factors were the greatest obstacles to treatment principles. 12, 13 Other previous studies agreed that barriers come from both individuals and the entire system. Therefore, HCV intervention should be a "combination intervention," that is, it should involve all possible barriers dimensions. 14, 16 Knowledge score was found to be statistically significant correlated with patients' and providers' barriers where it was found that physicians who scored lower on the knowledge assessment tended to perceive greater patients' barriers; therefore fewer patients would miss the treatment as a result of incorrectly perceived barriers. While Physicians with higher knowledge showed higher providers' barriers as they know what to do but they had barriers in providing care due to defect in supports and facilities.
These perceived barriers may be overcome through improved education and improved the support to facilities provide HCV treatment and these results were similar to other findings in McGowan et al., 2013 study. (9) Egyptian Family Medicine Journal (EFMJ) Vol .3(2), Nov. 2019 http://efmj.journals.ekb.eg/
Study limitation:
The current study was conducted in one hospital in Cairo, Egypt, thus physicians who completed the survey may not reflect the knowledge and opinions of all physicians in Egypt. Therefore, a better study design could have been adopted using sample of physicians from different types of hospitals in different governorates. Limited number of physicians' working in HCV treatment clinic who are eligible for participating in the study. There may be other barriers or facilities that prevent or enhance the HCV service that we did not examine in the current study. Future work will be conducted to clarify these issues especially from patients' perspective.
Conclusion:
The present study indicated that the majority 
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